Form 13-F position report

PHOENIX BIOTECH ACQUISITION

Reported by CANTOR FITZGERALD L P

PBAXU CUSIP 71902K204 Manager CIK 0001024896

Reported 0 shares, down 155,000 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q4 2022
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 5 Through Q4 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 1550000
2022-03-31 0
2022-06-30 1561000
2022-09-30 2000
2022-12-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

5 quarters
Quarterly reported position history for PHOENIX BIOTECH ACQUISITION held by CANTOR FITZGERALD L P.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2022 Reduced 0 -155,000 (-100.0%) 0 $0 2023-02-14
Q3 2022 Unchanged 155,000 0 (0.0%) < 0.01% $2,000 2022-11-14
Q2 2022 Unchanged 155,000 0 (0.0%) 0.03% $1,561,000 2022-08-15
Q1 2022 Unchanged 155,000 0 (0.0%) 0 $0 2022-05-16
Q4 2021 New 155,000 +155,000 (0.0%) 0.11% $1,550,000 2022-02-14

Who else reported the position

22 managers reported PHOENIX BIOTECH ACQUISITION for Q4 2022.

Managers reporting PHOENIX BIOTECH ACQUISITION in Q4 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Yakira Capital Management Inc Unchanged 100,000 0 0.21% $1,031,000 5 qtrs
FLOW TRADERS U S LLC Reduced 10,247 -1,236 < 0.01% $104,000 2 qtrs
Tower Research Capital LLC TRC Unchanged 175 0 < 0.01% $2,000 5 qtrs
UBS Group AG Reduced 0 -992 0 $0 5 qtrs
Silver Rock Financial LP Reduced 0 -46,243 0 $0 5 qtrs
WOLVERINE ASSET MANAGEMENT LLC Reduced 0 -17,262 0 $0 5 qtrs
DIFESA CAPITAL MANAGEMENT LP Reduced 0 -125,000 0 $0 5 qtrs
Schechter Investment Advisors LLC Reduced 0 -149,660 0 $0 5 qtrs
SUSQUEHANNA INTERNATIONAL GROUP LLP Reduced 0 -23,767 0 $0 2 qtrs
Cubist Systematic Strategies LLC Reduced 0 -25,471 0 $0 3 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2022
Filed
February 14, 2023
Filing type
13F-HR
Position type
UNIT 99/99/9999

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.